Rel-(1s,4s)-4-((tert-butoxycarbonyl)amino)-1-fluorocyclohexane-1-carboxylic acid

Catalog No.: 
ACXPKF876
CAS No.: 
2231665-56-6
Molecular Formula: 
C12H20FNO4
Molecular Weight: 
261.29
Rel-(1s,4s)-4-((tert-butoxycarbonyl)amino)-1-fluorocyclohexane-1-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$1178.00In stockInquiry
250mg95%$1964.00In stockInquiry
500mg95%$3273.00In stockInquiry
1g95%$4909.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRel-(1s,4s)-4-((tert-butoxycarbonyl)amino)-1-fluorocyclohexane-1-carboxylic acid
IUPAC Name(1s,4s)-4-((tert-butoxycarbonyl)amino)-1-fluorocyclohexane-1-carboxylic acid
Molecular FormulaC12H20FNO4
Molecular Weight261.29
SMILESO=C([C@@]1(F)CC[C@H](NC(OC(C)(C)C)=O)CC1)O
InChI KeyDZQALYALTWCYAS-LYWQIFSTSA-N
Synonymtrans-4-{[(tert-butoxy)carbonyl]amino}-1-fluorocyclohexane-1-carboxylic acid;(1R,4r)-4-((tert-butoxycarbonyl)amino)-1-fluorocyclohexane-1-carboxylic acid;trans-4-(tert-butoxycarbonylamino)-1-fluoro-cyclohexanecarboxylicacid
CAS No.2231665-56-6

Synthetic Route by SureRoute

1. ACXPKF876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXPKF876 route product structure diagram
    ACXPKF8762231665-56-6In Stock
Inquiry

2. ACXPKF876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXPKF876 route product structure diagram
    ACXPKF8762231665-56-6In Stock
Inquiry

3. ACXPKF876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXPKF876 route product structure diagram
    ACXPKF8762231665-56-6In Stock
Inquiry

Comments (0)